We used OB ≥ 30% and DL ≥ 0.18 as screening conditions in TCMSP for initial screening of drug ingredients. DL is a qualitative concept used in drug design for an estimate on how “drug-like” a prospective compound is, which helps to optimize pharmacokinetic and pharmaceutical properties, such as solubility and chemical stability.25 (link) OB indicates the percentage of an oral dose of unchanged drug that reaches the body’s circulation, and a high OB is often a key indicator for determining the properties of a biologically active molecule as a therapeutic agent.26 (link) Ingredients not recorded in TCMSP were screened using the SwissADME database for favorable gastrointestinal absorption and high DL values.27 (link) In addition, we found that certain ingredients, although not meeting the conditions of OB < 30% and DL < 0.18, have broad pharmacological activity or are known to be major components in SM (such as Ligustrazine,28 (link) Retinol,29 (link) etc.) and therefore should also be added as potential active ingredients in SM. The TCMSP database, the BATMAN database and Swiss Target Prediction30 (link) were collectively used as potential targets for predicting components, and the names of relevant targets were standardized through the UniProt database.31 (link)
Optimizing Herbal Medicine Composition Search
We used OB ≥ 30% and DL ≥ 0.18 as screening conditions in TCMSP for initial screening of drug ingredients. DL is a qualitative concept used in drug design for an estimate on how “drug-like” a prospective compound is, which helps to optimize pharmacokinetic and pharmaceutical properties, such as solubility and chemical stability.25 (link) OB indicates the percentage of an oral dose of unchanged drug that reaches the body’s circulation, and a high OB is often a key indicator for determining the properties of a biologically active molecule as a therapeutic agent.26 (link) Ingredients not recorded in TCMSP were screened using the SwissADME database for favorable gastrointestinal absorption and high DL values.27 (link) In addition, we found that certain ingredients, although not meeting the conditions of OB < 30% and DL < 0.18, have broad pharmacological activity or are known to be major components in SM (such as Ligustrazine,28 (link) Retinol,29 (link) etc.) and therefore should also be added as potential active ingredients in SM. The TCMSP database, the BATMAN database and Swiss Target Prediction30 (link) were collectively used as potential targets for predicting components, and the names of relevant targets were standardized through the UniProt database.31 (link)
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Beijing University of Chinese Medicine, Tianjin University of Traditional Chinese Medicine
Variable analysis
- Database selection and characteristics
- Screening conditions (OB ≥ 30% and DL ≥ 0.18) for initial screening of drug ingredients in TCMSP
- Using SwissADME database for screening ingredients not recorded in TCMSP
- Inclusion of certain ingredients not meeting the OB and DL conditions but known to have broad pharmacological activity or are major components in SM
- Comprehensive and accurate information on drug components and related targets
- Not explicitly mentioned
- No positive or negative controls were explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!